Monte Rosa Therapeutics, Inc. (GLUE)
10.30
-0.02
(-0.19%)
USD |
NASDAQ |
Oct 09, 16:00
10.30
0.00 (0.00%)
After-Hours: 20:00
Monte Rosa Therapeutics EPS Diluted (Quarterly) : -0.4276 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.4276 |
| March 31, 2026 | -0.4456 |
| December 31, 2025 | -0.7039 |
| September 30, 2025 | -0.3287 |
| June 30, 2025 | -0.1496 |
| March 31, 2025 | 0.5652 |
| December 31, 2024 | 0.2185 |
| September 30, 2024 | -0.2909 |
| June 30, 2024 | -0.4255 |
| March 31, 2024 | -0.5314 |
| December 31, 2023 | -0.5841 |
| September 30, 2023 | -0.7003 |
| June 30, 2023 | -0.7116 |
| Date | Value |
|---|---|
| March 31, 2023 | -0.6492 |
| December 31, 2022 | -0.6296 |
| September 30, 2022 | -0.5846 |
| June 30, 2022 | -0.5672 |
| March 31, 2022 | -0.5136 |
| December 31, 2021 | -0.5037 |
| September 30, 2021 | -0.4268 |
| June 30, 2021 | -0.4126 |
| March 31, 2021 | -0.279 |
| December 31, 2020 | -0.4517 |
| September 30, 2020 | -0.147 |
| June 30, 2020 | -0.1219 |
| March 31, 2020 | -0.0978 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| United Therapeutics Corp. | 7.271 |
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Alnylam Pharmaceuticals, Inc. | 1.207 |
| Anika Therapeutics, Inc. | 0.2412 |
| Savara, Inc. | -0.1587 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -43.40M |
| Revenue (Quarterly) | 8.968M |
| Total Expenses (Quarterly) | 52.36M |
| Enterprise Value | 294.71M |
| Gross Profit Margin (Quarterly) | 78.69% |
| Profit Margin (Quarterly) | -483.9% |
| Earnings Yield | -18.50% |
| Normalized Earnings Yield | -18.50 |